Is there still room for large registrative trials in unselected cancer patients? The case of anti-epidermal growth factor receptor antibodies in advanced non-small-cell lung cancer

By Di Maio Massimo  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 9, 2011-09 ,pp. : 1131-1133

Informa Healthcare

Access to resources Recommend Favorite

Epidermal growth factor receptor (EGFR) mutations as biomarker for head and neck squamous cell carcinomas (HNSCC)

By Nagalakshmi K.   Jamil Kaiser   Pingali Usharani   Reddy M. Vishnuvardhan   Attili Suresh S. V.  

Biomarkers, Vol. 19, Iss. 3, 2014-05 ,pp. : 198-206

Informa Healthcare

Access to resources Recommend Favorite

Molecular biology of epidermal growth factor receptor inhibition for cancer therapy

By Oliveira Sabrina   van Bergen en Henegouwen Paul MP   Storm Gert   Schiffelers Raymond M  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 6, 2006-06 ,pp. : 605-617

Informa Healthcare

Access to resources Recommend Favorite

Human epidermal growth factor receptor 2-targeted therapies in breast cancer

By Nahta Rita  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 7, 2013-09 ,pp. : 949-952

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant treatment of breast cancer: impact of monoclonal antibody therapy directed against the HER2 receptor

By Simonds Hannah M   Miles David  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 4, 2007-04 ,pp. : 487-491

Informa Healthcare

Access to resources Recommend Favorite